Zayas Ricardo 4
4 · AMAG PHARMACEUTICALS INC. · Filed Jun 9, 2010
Insider Transaction Report
Form 4
Zayas Ricardo
Sr. Vice President, Operations
Transactions
- Sale
Common Stock
2010-06-09$32.45/sh−100$3,245→ 10,892 total - Conversion
Common Stock
2010-06-08+2,500→ 12,087 total - Sale
Common Stock
2010-06-08$32.47/sh−400$12,988→ 11,287 total - Sale
Common Stock
2010-06-08$32.46/sh−100$3,246→ 11,687 total - Sale
Common Stock
2010-06-09$32.46/sh−295$9,576→ 10,992 total - Conversion
Restricted Stock Unit
2010-06-08+2,500→ 2,500 total→ Common Stock (2,500 underlying) - Sale
Common Stock
2010-06-08$32.46/sh−300$9,738→ 11,787 total
Footnotes (3)
- [F1]Not applicable.
- [F2]Each restricted stock unit represents a contingent right to receive one unit of the Issuer's common stock.
- [F3]Grant of restricted stock unit pursuant to AMAG Pharmaceuticals, Inc.'s Amended and Restated 2007 Equity Incentive Plan. The grant is exercisable in four equal installments. The first installment vested on June 8, 2010, the first anniversary of the grant. The remaining installments will vest on June 8, 2011, June 8, 2012, June 8, 2013, respectively.